Pneumonias Flashcards
Most common agents typical pneumonia
Strep pneumonia e
H flu
Moraxella
Staph aureus
Most common agents atypical “walking” pneumonia
Mycoplasma. Pneumonia e
Legionella
Chlamydophilia pneumonia e
Chlamydia_psittaci
All hard to culture can’ t be seen on gram
Most live in host cells
Most abundant immune cell pneumonia
Neutrophils
Aspiration pneumonia typical agents
Kleibsella
Anaerobes
Acinetobacter
Alcoholism
Hap most common agents
MR sa
Pseudomonas
Acinetobacter
Enterobacterlacaec
Legionella
Burkholderia
Agents with a higher risk in smoking and copd
Atypical
Pseudomonas
Legionella risks
Travel, hotel, cruises
Staph aureus pneumonia risks
Secondary after flu
Structural lung disease
Bird pneumonia
- Chlamydia-psittaci
Rabbit pneumonia
Francisella-tularensiis
Sheep /goat pneumonia
. Coxiella burnetii
Encapsulated bacteria
S pneumonia
H flu
Protects from phagocytosis
Legionella defenses
Macrophage infector protein
Type 4 secretion system
Grows inside macrophages
Uses iron
S aureus toxin involved in phenomena
Alpha-hemolysi n
- pore forming eytotoxin
Mycoplasma penicillins
No-go, they don’t have a cell wall
Chlamydophiliavirulenufactor
Type 3 secretion system
Lives in macrophages
Enterococci virulence factor
MSR - vanA vancomycin
Outpatient cap Tx
. Macrolide- azithromycin
Or doxy
If recent ab x or high risk:
- azithromycin with ceftriaxone
- respiratory fluroquinolone eg. Levo floxacin
Inpatient cap Tx
- azithromycin with ceftriaxone
- respiratory fluroquinolone eg. Levo floxacin,
In iv form
Pseudomonas empiric coverage
Pip/tazo
MRSA empiric coverage
Vancomycin or linezolid
Antigenic- shift
Major changes due to reassortment
Usually used for flu to mean new subtype
Antigenic drift
Minor changes due to point mutations
Pharyngocongunctival fever
Pharyngitis- conjuncevitis- fever
Adenovirus
Adenovirus genome
Ds DNA
RSV
Paramyxovirus
Ssrna
F protein in envelope Fuses neighboring cells together →multinucleated synciftia
G protein in envelopes → attachment
Palivizumab
Anti-rsv
Prophylaxis for at-risk infants eg. Cyanotic heart failure, bronchopulmonary dysplasia
Not usually needed for tx
Hantavirus
Rural areas, se US
Rodents
Pulmonary edema dt infection ofendothelial cells in lung
Potentially fatal
* thrombocytopenia - prolonged pt and ptt
Measles signs
Fever first
Cough- rinorrhea - conjunctivitis
Kopek spots buccal mucosa
Macalopapular rash
Vzv pneumonia
Ic
Typical vzv signs plus prolonged fever i cough
N odular lung lesions X-ray
CMV pneumonia
Ic
Interstitial pneumonia
Non-productive cough
* Neutropenia (Low)
Elevated lfts
Mucosal ulcers
Flu a/b Tx
Peramivir, zanamimi, oseltamivir
All neuraminidase in hibitors
Indirect flu A Tx
Amantidine
Rimantadine
Both nicotinic (and mixed other) agonists
RSV t x
Ribavirin (also used for hep c)
Palivizumab (mostly prophylactic s
VSV Tx
Acyclovir
CMV Tx
Ganciclovir, valganciclovir
Foscarnet (DNA/RNA polymerase innibitor)
Coronaviruses structure
Enveloped
Linear ss POS sense RNA
COVID entry cell
Type 2 pneumocytes
Lack of surfactant worsens sx